vs

Side-by-side financial comparison of Inogen Inc (INGN) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $68.6M, roughly 1.0× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-1.9M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -4.7%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

INGN vs RMAX — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.0× larger
RMAX
$71.1M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+5.3% gap
INGN
3.4%
-1.8%
RMAX
More free cash flow
RMAX
RMAX
$35.4M more FCF
RMAX
$33.5M
$-1.9M
INGN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
RMAX
RMAX
Revenue
$68.6M
$71.1M
Net Profit
$1.4M
Gross Margin
51.4%
Operating Margin
-13.6%
13.1%
Net Margin
2.0%
Revenue YoY
3.4%
-1.8%
Net Profit YoY
-75.2%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
RMAX
RMAX
Q4 25
$68.6M
$71.1M
Q3 25
$79.1M
$73.2M
Q2 25
$79.2M
$72.8M
Q1 25
$68.5M
$74.5M
Q4 24
$66.3M
$72.5M
Q3 24
$74.9M
$78.5M
Q2 24
$74.4M
$78.5M
Q1 24
$63.1M
$78.3M
Net Profit
INGN
INGN
RMAX
RMAX
Q4 25
$1.4M
Q3 25
$-5.3M
$4.0M
Q2 25
$-4.2M
$4.7M
Q1 25
$-6.2M
$-2.0M
Q4 24
$5.8M
Q3 24
$-6.0M
$966.0K
Q2 24
$-5.6M
$3.7M
Q1 24
$-14.6M
$-3.4M
Gross Margin
INGN
INGN
RMAX
RMAX
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
RMAX
RMAX
Q4 25
-13.6%
13.1%
Q3 25
-9.0%
25.0%
Q2 25
-7.7%
19.3%
Q1 25
-11.2%
7.2%
Q4 24
-17.2%
5.9%
Q3 24
-10.4%
19.4%
Q2 24
-9.5%
20.6%
Q1 24
-25.8%
5.8%
Net Margin
INGN
INGN
RMAX
RMAX
Q4 25
2.0%
Q3 25
-6.7%
5.4%
Q2 25
-5.2%
6.4%
Q1 25
-9.0%
-2.6%
Q4 24
8.0%
Q3 24
-8.0%
1.2%
Q2 24
-7.5%
4.7%
Q1 24
-23.1%
-4.3%
EPS (diluted)
INGN
INGN
RMAX
RMAX
Q4 25
$-0.26
Q3 25
$-0.20
Q2 25
$-0.15
Q1 25
$-0.25
Q4 24
$-0.41
Q3 24
$-0.25
Q2 24
$-0.24
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$103.7M
$118.7M
Total DebtLower is stronger
$432.2M
Stockholders' EquityBook value
$192.2M
$452.4M
Total Assets
$298.6M
$582.5M
Debt / EquityLower = less leverage
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
RMAX
RMAX
Q4 25
$103.7M
$118.7M
Q3 25
$106.5M
$107.5M
Q2 25
$103.7M
$94.3M
Q1 25
$118.9M
$89.1M
Q4 24
$113.8M
$96.6M
Q3 24
$105.7M
$83.8M
Q2 24
$97.9M
$66.1M
Q1 24
$107.4M
$82.1M
Total Debt
INGN
INGN
RMAX
RMAX
Q4 25
$432.2M
Q3 25
$433.3M
Q2 25
$434.4M
Q1 25
$435.3M
Q4 24
$436.2M
Q3 24
$437.2M
Q2 24
$438.1M
Q1 24
$439.0M
Stockholders' Equity
INGN
INGN
RMAX
RMAX
Q4 25
$192.2M
$452.4M
Q3 25
$197.2M
$448.1M
Q2 25
$199.5M
$442.4M
Q1 25
$198.0M
$433.5M
Q4 24
$173.9M
$429.5M
Q3 24
$185.4M
$423.1M
Q2 24
$187.6M
$418.4M
Q1 24
$191.9M
$412.0M
Total Assets
INGN
INGN
RMAX
RMAX
Q4 25
$298.6M
$582.5M
Q3 25
$307.0M
$582.2M
Q2 25
$312.0M
$574.8M
Q1 25
$308.4M
$571.4M
Q4 24
$296.2M
$581.6M
Q3 24
$306.2M
$578.6M
Q2 24
$308.9M
$571.4M
Q1 24
$315.6M
$566.7M
Debt / Equity
INGN
INGN
RMAX
RMAX
Q4 25
0.96×
Q3 25
0.97×
Q2 25
0.98×
Q1 25
1.00×
Q4 24
1.02×
Q3 24
1.03×
Q2 24
1.05×
Q1 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
RMAX
RMAX
Operating Cash FlowLast quarter
$-943.0K
$40.9M
Free Cash FlowOCF − Capex
$-1.9M
$33.5M
FCF MarginFCF / Revenue
-2.8%
47.1%
Capex IntensityCapex / Revenue
1.4%
10.4%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
RMAX
RMAX
Q4 25
$-943.0K
$40.9M
Q3 25
$2.2M
$17.7M
Q2 25
$4.3M
$4.6M
Q1 25
$-16.8M
$5.7M
Q4 24
$-3.0M
$59.7M
Q3 24
$7.0M
$17.6M
Q2 24
$6.7M
$15.9M
Q1 24
$-4.7M
$9.4M
Free Cash Flow
INGN
INGN
RMAX
RMAX
Q4 25
$-1.9M
$33.5M
Q3 25
$1.6M
$16.4M
Q2 25
$3.7M
$2.9M
Q1 25
$-17.1M
$4.0M
Q4 24
$-3.3M
$53.0M
Q3 24
$5.3M
$16.3M
Q2 24
$6.6M
$14.0M
Q1 24
$-6.1M
$6.8M
FCF Margin
INGN
INGN
RMAX
RMAX
Q4 25
-2.8%
47.1%
Q3 25
2.0%
22.4%
Q2 25
4.6%
4.0%
Q1 25
-24.9%
5.3%
Q4 24
-5.0%
73.2%
Q3 24
7.1%
20.8%
Q2 24
8.9%
17.8%
Q1 24
-9.6%
8.6%
Capex Intensity
INGN
INGN
RMAX
RMAX
Q4 25
1.4%
10.4%
Q3 25
0.7%
1.8%
Q2 25
0.9%
2.2%
Q1 25
0.4%
2.3%
Q4 24
0.5%
9.1%
Q3 24
2.2%
1.7%
Q2 24
0.1%
2.4%
Q1 24
2.1%
3.3%
Cash Conversion
INGN
INGN
RMAX
RMAX
Q4 25
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
Q4 24
10.28×
Q3 24
18.22×
Q2 24
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons